Jun 13, 2026
Jun 13, 2026
Jun 13, 2026
Jun 13, 2026
Jun 13, 2026
Jun 13, 2026
Jun 13, 2026
Jun 13, 2026
Pfizer faces a challenging path as its COVID-19 products lose demand and key drug patents near expiration. The implications for investors and industry ripple wider than expected.